莱斯康制药

$莱斯康制药(LXRX)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001193125-26-041416  Act: 34  Size: 20 KB 网页链接

$莱斯康制药(LXRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-037644  Size: 59 KB 网页链接

$莱斯康制药(LXRX)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001193125-26-034176  Act: 34  Size: 399 KB 网页链接

$莱斯康制药(LXRX)$ 8-K Current report, items 1.01, 3.02, 3.03, 5.03, 7.01, and 9.01 Accession Number: 0001193125-26-033793  Act: 34  Size: 731 KB 网页链接

$莱斯康制药(LXRX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-26-033160  Act: 33  Size: 460 KB 网页链接

$莱斯康制药(LXRX)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001193125-26-029894  Act: 34  Size: 19 KB 网页链接

$莱斯康制药(LXRX)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001193125-26-030233  Act: 34  Size: 21 KB 网页链接

$莱斯康制药(LXRX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-26-029498  Act: 33  Size: 457 KB 网页链接

$莱斯康制药(LXRX)$ 8-K Current report, items 2.02, 7.01, 8.01, and 9.01 Accession Number: 0001193125-26-029514  Act: 34  Size: 167 KB 网页链接

$莱斯康制药(LXRX)$ 8-K Current report, item 8.01 Accession Number: 0001193125-25-274383  Act: 34  Size: 137 KB 网页链接

$莱斯康制药(LXRX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-25-270167  Act: 33  Size: 347 KB 网页链接

$莱斯康制药(LXRX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-25-270020  Act: 34  Size: 160 KB 网页链接

$莱斯康制药(LXRX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001062822-25-000054  Act: 34  Size: 5 MB 网页链接

$莱斯康制药(LXRX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001062822-25-000049  Act: 34  Size: 229 KB 网页链接

$莱斯康制药(LXRX)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001628280-25-038387  Act: 33  Size: 224 KB 网页链接

$莱斯康制药(LXRX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-25-038340  Act: 34  Size: 5 MB 网页链接

$莱斯康制药(LXRX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001062822-25-000042  Act: 34  Size: 232 KB 网页链接

$莱斯康制药(LXRX)$ 8-K Current report, item 8.01 Accession Number: 0001062822-25-000037  Act: 34  Size: 135 KB 网页链接

$莱斯康制药(LXRX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000315066-25-001680  Act: 34  Size: 11 KB 网页链接

$莱斯康制药(LXRX)$ 8-K Current report, item 8.01 Accession Number: 0001062822-25-000035  Act: 34  Size: 136 KB 网页链接